Iambic Therapeutics Shares Sink Following Wider 3Q Loss
By Connor HartShares of Iambic Therapeutics fell after the company reported a wider loss in the recent quarter.The stock declined 11%, to $11.60, on Monday. The company had its public debut last month, selling nearly 9.38 million shares of its common stock for $16 apiece.The life-sciences and techn…